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Abstract 
Background. Body dysmorphic disorder (BDD) is a debilitating disorder, characterised by 
obsessions and compulsions relating specifically to perceived appearance, newly classified within 
the DSM-5 Obsessive-Compulsive and Related Disorders grouping. Until now, little research has 
been conducted into the cognitive profile of this disorder.  
Materials and Methods. Participants with BDD (n=12) and healthy controls (n=16) were tested 
using a computerised neurocognitive battery investigating attentional set-shifting (Intra/Extra 
Dimensional Set Shift Task), decision-making (Cambridge Gamble Task), motor response-inhibition 
(Stop-Signal Reaction Time Task) and affective processing (Affective Go-No Go Task). The groups 
were matched for age, IQ and education. 
Results. In comparison to controls, patients with BDD showed significantly impaired attentional set 
shifting, abnormal decision-making, impaired response inhibition and greater omission and 
commission errors on the emotional processing task.  
Conclusions. Despite the modest sample size, our results showed that individuals with BDD 
performed poorly compared to healthy controls on tests of cognitive flexibility, reward and motor 
impulsivity and affective processing. Results from separate studies in OCD patients suggest similar 
cognitive dysfunction. Therefore, these findings are consistent with the re-classification of BDD 
alongside OCD. These data also hint at additional areas of decision-making abnormalities that might 
contribute specifically to the psychopathology of BDD. 
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Introduction 
Individuals with Body Dysmorphic Disorder (BDD) are troubled by intrusive thoughts that they 
have a bodily imperfection that is visibly unsightly (Grant & Phillips, 2005). In some cases, they 
have a minor physical flaw that would not be regarded as abnormal or noticeable by most people; in 
other cases, the defect is imaginary. They fear showing the ‘imperfection’ in public (Rosen, 1995), 
leading to social avoidance and isolation (Goodman et al., 1989). They spend considerable time 
ruminating about the perceived defect, and engage in time consuming checking, camouflaging and 
reassurance-seeking rituals (Veale, 2001).   
 
BDD has been relatively neglected by research, perhaps in part due to the assumption that it is a rare 
condition. However, extant epidemiological data contradict this perspective.  In a German sample of 
approximately 2500 individuals, selected to be representative of the general population, the point 
prevalence of BDD was estimated at 1.2-2.1% (Rief et al., 2006). In a national household telephone 
survey conducted in approximately 2000 US citizens, the point prevalence was estimated at 2.4% 
(Koran et al., 2008). Other studies, mostly conducted in college student samples, suggest a point 
prevalence rates of around 2.5% or greater (Biby 1998; Bohne et al., 2002a,b; Sarwar et al., 2005). 
In addition to being relatively common, BDD is associated with profound impairment in quality of 
life and everyday functioning (Koran et al., 2008). Insight is frequently impaired and treatment-
adherence is noted to be poor (Rashid et al., 2014). Furthermore, a prospective study conducted over 
four years in 185 subjects with BDD indicates that suicidality is a major concern. Each year, suicidal 
ideation occurred in more than 50% of individuals with BDD, 2.6% attempted suicide, and 0.3% 
completed suicide (Phillips and Menard, 2006).   
 
In recognition of its nosological status as a compulsive disorder, the DSM-5 has moved BDD into 
the same category as obsessive compulsive disorder (OCD), under an expanded grouping of 
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Obsessive Compulsive and Related Disorders (APA, 2013). Studies have demonstrated co-morbid 
and familial overlap between OCD and BDD (Thornton and Russell, 1997; Bienvenu et al, 2000). In 
those with OCD, co-morbid BDD has been reported in up to 37% of cases (Conceição Costa et al., 
2012). Furthermore, in two seminal OCD family studies, the first-degree relatives of OCD probands 
were at significantly elevated risk for BDD, as well as trichotillomania, skin picking disorder and 
hypochondriasis, as compared to control relatives (Bienvenu et al., 2000, 2012). These findings are 
suggestive of a familial overlap between BDD and OCD on the one hand and between BDD and 
other putative obsessive compulsive and related disorders on the other, perhaps mediated by 
common genetic and/or cognitive predisposing factors. 
 
Understanding of the neurobiology of BDD and related conditions can be informed by the use of 
well-validated cognitive tests that probe the integrity of the fronto-striatal neurocircuitry. Various 
cognitive impairments have been identified in OCD using computerised paradigms from the 
Cambridge Neuropsychological Test Automated Battery (CANTAB 
www.cambridgecognition.com), including in the domains of set-shifting (Extra-Dimensional Set-
Shift (EDS)), inhibitory motor control (Stop-Signal Reaction Time (SSRT)), executive planning 
(Stockings of Cambridge (SOC) test), and affective bias toward negatively-valenced stimuli (for 
reviews see Chamberlain et al., 2005, Fineberg et al., 2010, Fineberg et al 2014). For some deficits 
(Extra-Dimensional Set-Shift, Stop-Signal Reaction Time, Stockings of Cambridge), similar 
cognitive dysfunction exists in unaffected first-degree relatives of patients with OCD and these 
therefore may represent predisposing or ‘vulnerability’ markers (e.g. Chamberlain et al., 2007a; 
Cavedini et al., 2010; Rajender et al., 2011; Vaghi et al., 2014). The findings are broadly consistent 
with current neurobiological models of OCD, which implicate not only dysfunction within the 
classical orbitofrontal circuitry but also the dorsolateral prefrontal cortical circuitry, which 
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incorporate these cortical regions but also subcortical nodes including the ventral and dorsal striatum 
(Menzies et al., 2008; Fineberg et al., 2010, Vaghi et al., 2014).  
There have been few published studies exploring neuropsychological function in BDD.  Hanes and 
colleagues compared 14 subjects with BDD with 10 subjects with OCD and 24 controls, using a 
variety of non-computerised tests (Hanes, 1998). Both the BDD and OCD groups were similarly 
impaired, compared to controls, on tests of executive planning (Tower of London task) and colour-
word interference (Stroop task), supporting the hypothesis that these two conditions are 
neurobiologically related. No significant deficits emerged in the BDD or OCD groups for category 
fluency and motor skill/speed on the Purdue Pegboard task, verbal learning on the Rey Auditory 
Verbal Learning task, or non-verbal learning/memory function on the Rey Complex Figures task 
(RCFT). In contrast, another study (Deckersbach et al., 2000), again using non-computerised tests, 
identified impairment in non-verbal learning/mnemonic domains (Rey Complex Figures Task), 
along with verbal learning impairment (California Verbal Learning Test), in 17 patients with BDD 
compared to 17 healthy controls. The authors postulated that the deficits were mediated by poor 
organisational strategy. Dunai and colleagues (2009) additionally explored cognitive functioning in 
14 patients with BDD versus 14 healthy controls, using selected computerised paradigms from the 
CANTAB. Patients with BDD were impaired on spatial working memory (Spatial Working Memory 
test) and executive planning (SOC test); findings similar to those reported separately for OCD 
(Chamberlain et al., 2006). In a more recent study, executive dysfunction was investigated in 14 
BDD participants, 14 matched (age and gender) healthy controls, and 23 participants with OCD. 
Similarities were seen in the BDD and OCD groups in spatial span, spatial working memory, pattern 
recognition and spatial planning (SOC) tasks compared with healthy controls. However, those with 
BDD were found to have relatively greater deficits in executive functioning, on the accuracy 
measure of the SOC Task, than those with OCD and compared with healthy controls (Labuschagne 
et al., 2013). 
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 Based on the above limited evidence, the current study sought to explore specific aspects of 
cognitive functioning in BDD and healthy volunteers using relevant tests from the CANTAB. We 
focused on motor response inhibition (using the SSRT), cognitive flexibility (using the Intra-Extra 
Dimensional (IED) Set Shifting Task), and affective processing using the Affective Go/NoGo task 
(AGN). These three cognitive domains are linked to behavioural inhibition and have not previously 
been investigated in BDD, but have been found to be impaired in non-comorbid OCD (Chamberlain 
et al., 2006). We also included a test of decision-making (Cambridge Gambling Task- CGT), which 
tests aspects of reward-based impulse control, and which has previously been observed to be intact 
in OCD (Chamberlain, 2006), but which is impaired in patients with behavioural and substance 
addiction (Zois et al 2014, Fineberg et al 2014). It was hypothesised that BDD would be associated 
with a similar cognitive profile to that previously reported in OCD: namely, significantly impaired 
response inhibition and set-shifting, evidence of affective bias with increased sensitivity to 
negatively-valenced cues, but intact decision-making.  
 
Materials and Methods 
 
Participants 
BDD patients, aged between 18 and 65 years of age, were recruited from the specialist OCD/BDD 
outpatient clinic of one of the authors (NAF).  All had a DSM-IV diagnosis of BDD, ascertained by 
a detailed clinical assessment amplified by the Yale Brown Obsessive Compulsive Checklist and 
Scale for Body Dysmorphic Disorder (BDD-YBOCS, Goodman et al, 1989) to determine the degree 
of illness severity. In order to meet the inclusion criteria for the study, BDD was required to 
constitute the primary illness. All psychiatric comorbidity (such as OCD) as documented in the case 
notes was recorded.  
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 Healthy, age, IQ and education-matched control participants were recruited from the University of 
Hertfordshire. Participants were approached within the University premises or via the university’s 
SONA system (an online computerised system by which students can indicate their interest in 
participating in research studies). Participants were screened to exclude the presence of Body 
Dysmorphic Disorder symptoms using the BDD-YBOCS using a cut off of >10. None of the 
participants in the control group scored more than 10 on this clinical rating scale. They were not 
formally screened for any other axis-I morbidity. 
 
Clinical measures 
Severities of depression and anxiety symptoms were quantified in all participants using the 
Montgomery-Åsberg Depression Rating Scale (MADRS, Montgomery and Ǻsberg, 1979) and the 
Hamilton Anxiety Scale (HAM-A, Hamilton, 1979). 
 
Neuropsychological Measures 
Participants completed the following paradigms from the CANTAB - see below. The tasks were 
administered in a fixed order (as below), in a quiet testing environment, supervised by a trained test 
administrator.  
 
The intra/extra dimensional set-shift task (IED- http://www.cambridgecognition.com/tests/intra-
extra-dimensional-set-shift-ied)  
This is a nine-stage visual discrimination task and measures cognitive flexibility (Lawrence et al, 
1998). Two stimuli are presented at a time, on a black screen and the task requires the participant to 
ascertain, by trial and error, and by computerised feedback, which of the stimuli is correct, and thus, 
the ‘rule’ of the game. At the start of each stage, the rule is altered. To successfully pass each stage, 
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six consecutive indications of the correct stimulus must be achieved within 50 trials, otherwise, the 
task terminates. The extra dimensional shift (EDS) stage of the task is crucial for determining 
divergent thinking deficits as the participant is required to shift their attentional focus from the 
previously relevant stimulus dimension to a previously irrelevant stimulus dimension.  Such set-
shifting depends on the ventrolateral prefrontal cortex (vlPFC- e.g. Hampshire & Owen, 2006). The 
outcome measures of interest on this task include the total number of errors and total number of 
stages successfully completed. Where these global parameters differ significantly between groups, 
performance on individual stages of the task can be explored to account for the data.  
 
The Cambridge Gambling Task (CGT- http://www.cambridgecognition.com/tests/cambridge-
gambling-task-cgt)  
This task assesses dissociable aspects of decision-making. Participants are asked to accumulate as 
many points as they can by making gambles across a range of different winning probabilities. Each 
trial shows 10 boxes (red or blue) across the top of a blank screen and participants are informed that 
a yellow token may be found under one of the blocks. Each trial has differing proportions of red and 
blue boxes. Participants are given 100 points to begin the gambling process and must choose which 
colour they think the token is under. Based on their confidence in their choice, they must place a bet 
on the location of the token. The bet amount either increases incrementally  (5%, 25%, 50%, 75%, 
95% of total collected points) or decreases (reverse order) over time. Outcome measures include 
mean percentage of points gambled (total proportion of overall bets), quality of decision-making 
(this measures rational decision making and is measured by the calculating the proportion of trials 
where the participant chose the more likely outcome (box colour), risk taking (the mean proportion 
of points bet on trials where the most likely outcome was chosen), deliberation time (how long it 
took to decide on which bet to choose) and delay aversion; this is measured as the tendency for 
participants to bet larger amounts due to an unwillingness, or inability, to wait for bets to decrease 
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on trials where bet amounts are presented in descending order compared with when bets are 
presented in ascending order. The delay aversion variable is calculated by subtracting the risk taking 
measure for ascending trials from risk taking in descending trials. Decision-making tasks, such as the 
CGT, have been regarded as sensitive measures of orbitofrontal cortex (OFC) pathology in 
psychiatric disorders (Clark et al, 2004). For example, individuals with OFC damage have been 
found to show impaired functioning on quality of decision making, longer deliberation times and 
reduced betting amounts (Rogers et al., 2000). 
 
The Stop Signal Task (SST- http://www.cambridgecognition.com/tests/stop-signal-task-sst)  
This is a measure of pre-potent motor inhibition. On this computerised task, participants are required 
to respond rapidly to left or right oriented arrows, presented on a blank screen. When an audible 
sound emits (the ‘stop-signal’) from the task screen, participants are required to inhibit their 
response for that arrow and their degree of success is measured. Over the course of the test, the time 
between the presentation of the ‘go’ stimulus and the ‘stop-signal’ varies using a tracking algorithm. 
The main outcome measure on the task is the Stop-Signal Reaction Time (SSRT), which is an 
estimate of the time taken by the given individual to stop or suppress a response that would 
ordinarily be undertaken; longer SSRTs equate to poorer motor response inhibition, or greater 
‘motor impulsivity’. The SSRT is thought to depend on the integrity of the right inferior frontal 
cortex and its subcortical connections, and is impaired in disorders associated with motor impulsivity 
such as attention deficit hyperactivity disorder and behavioural addiction (Chamberlain et al 2014) 
as well as OCD (Chamberlain et al., 2006; Menzies et al, 2007). The other outcome measure of 
interest is the median reaction time for ‘go’ trials; a generic measure of response speed not relating 
to inhibitory control.  
 
The Affective Go/NoGo (AGN- http://www.cambridgecognition.com/tests/affective-go-no-go-agn) 
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This task assesses mood processing bias.  A series of positive and negative words are presented on 
screen. The participant is required to respond to predetermined ‘target’ words by pressing a key pad 
when they see a target word. This target word will be ‘positive’ or ‘negative’ in valence. Other non-
affective words are considered ‘distractor’ words and participants are required to avoid responding 
to these words and to only respond to the ‘target’ word. The outcome variables of interest include the 
mean correct latency representing the length of time each participant takes to respond to target 
words, as well as the total number of commission errors (pressing for a positive target word when it 
is a negative one or vice-versa) and omission errors (failing to respond when one should have done 
so) . This task is sensitive to abnormal affective processing bias in major depressive disorder, and is 
thought to be mediated by mood-cognition interactions, sub-served by the orbitofrontal cortex and 
associated neural regions (Murphy et al., 1999), including the cingulate gyrus (Elliott et al, 2000). 
 
Statistical analysis 
Between-group differences were investigated by conducting a multivariate Analysis of Variance 
(MANOVA) using IBM SPSS. Further exploratory analysis in SPSS included a test of covariance 
using anxiety (Ham-A) and depression (MADRS) scores as covariates. This being an exploratory 
study, statistical significance was defined as p<0.05 uncorrected.  
 
Results 
 
Demographic analysis 
12 individuals with BDD (mean duration of illness 133.5 months [11.13 years]) and 16 healthy 
controls completed cognitive tasks and clinical questionnaires (Table 1). Importantly, the two groups 
did not differ significantly with regard to age, education and estimated IQ using the National Adult 
Reading Test (NART, Nelson, 1982: see Table 1).  
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 Table one about here 
 
 
Clinical analysis  
The BDD group showed a range of symptom-severity ranging from mild to moderately severe 
(BDD-YBOCS total range 7-24). The mean BDD Y-BOCS was 13.25 (SD 4.88), representing mild 
BDD. Control BDD-YBOCS scores ranged from 0-10 with an average score of 2.38 (SD= 3.40). 
None of the 16 control participants were taking prescribed medication, while all 12 of the BDD 
participants were taking prescribed medication (2 citalopram, 6 escitalopram, 3 fluvoxamine and 1 
sertraline). Nine of the twelve BDD patients expressed symptoms of comorbid illnesses (all 9 
patients showed comorbid OCD within the clinical range, 2 of those 9 were also diagnosed with 
social anxiety disorder and 1 patient exhibited gender identity disorder (GID)). Although both 
groups showed low levels of anxiety and depressive symptomatology, the BDD group showed 
significantly greater severity of symptoms of depression (MADRS,  p=.01), and anxiety (Ham A 
p=.03) – see Table 2. Fifty per cent of the participants with BDD scored very low on the MADRS 
(‘normal or symptom absent’ with a MADRS score of less than 7 [Muller-Thompson 2005; 
McDowell, 2006]). The majority of the remainder (n=5) scored within the ‘mild depression’ with 
scores between 7 and 19, and 1 participant scored 24 representing ‘moderate depression’ (Muller-
Thompson 2005; McDowell, 2006). 
 
Table 2 about here 
 
Neurocognitive analysis. 
 
Intra/Extra Dimensional set shift task (IED) 
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The BDD group made significantly more total errors (adjusted) on the task versus controls (Mean 
BDD 26.75 (SD 10.85) vs controls 13.18 (SD 4.98); F(1,26)= 14.27, p= .001; Cohen’s d= 1.54). 
These errors were specifically seen at the extra-dimensional shift (EDS) stage (stage 8) (Mean 17.25 
[SD 12.10] vs 4.75[SD 3.92] (F(1,26)= 10.56, p= .003; Cohen’s d= 1.32)). All participants in both 
groups passed stages 1-7; however, only 50% (n=6) of the BDD group passed the EDS stage while 
all control participants (n=16) passed the EDS stage (see Figure 1). No notable changes to the 
significance of each variable were seen when results were co-varied for anxiety and depression. 
 
 
Figure 1 about here 
 
Stop Signal Task (SST) 
The BDD group showed significantly longer stop-signal reaction times (SSRTs) than the controls 
(F(1,26)= 4.66, p= .04; Cohen’s d= .87). General psychomotor speed (measured as median ‘go’ 
reaction times) did not differ significantly between the groups (p= .77).  
 
Cambridge Gambling Task (CGT) 
The BDD group showed significantly more delay aversion than controls (F(1,26)= 5.22, p= .03, 
Cohen’s d=.94). However, the BDD group gambled a significantly smaller proportion of total points 
overall (F(1,26)= 63.16, p <.001, Cohen’s d= 3.24 [large effect size]). Between-group differences 
were also found in risk taking (measured by the proportion of total points bet over all trials), with the 
BDD group showing a significantly lower incidence of risk taking (F(1,26)= 4.72, p=.04, Cohen’s 
d=-1.25) than controls. Groups did not differ significantly in terms of the proportion of rational 
decisions made overall. (Rational decision making on ascending [p= .43] and descending [p= .93] 
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trials). No significant differences were found with regard to the deliberation time when making bets 
(F(1,26)=1.84, p= .18, Cohen’s d= .55). 
 
Affective Go/ No-Go (AGN) 
 
Reaction time 
Analysis of variance showed that the BDD group were slower to respond correctly to presented 
words than the controls (F(1,26)=4.85, p= .03, Cohen’s d= .90). Sub-analysis indicated that 
individuals with BDD took significantly longer to respond to positive words when compared to 
controls (Means: BDD 535; control 473.22; F(1,26)=19.77, p <.001, Cohen’s d= 1.81). The groups 
did not differ significantly for negative words. 
 
Commissions 
ANOVA showed that the number of commission errors differed significantly between the groups, 
due to higher errors in patients than controls overall (means BDD 10.17 (SD 7.66); control 4.62 (SD 
2.09); F(1,26)=5.86, p= .02, Cohen’s d= .97). Sub-analysis indicated that there were significantly 
more commission errors in patients than controls for positively valenced words (Means: BDD 2.33; 
control .94; F(1,26)=5.85, p= .02, Cohen’s d= 1.39), and for negative words (Means: BDD 3.75; 
control .75; F(1,26)=10.78, p= .003, Cohen’s d= .79); but not neutral words (Means: BDD .00; 
control .18; F(1,26)= .50, p= .48, Cohen’s d= .29). 
 
Omissions 
More non-responses (omissions) were seen in the BDD group compared with controls overall 
(F(1,26)=24.44, p<.001, Cohen’s d= 2.00). When exploring emotional valence, the BDD group 
made statistically more omissions for positively valenced words (Means: BDD 1.33; control .13; 
F(1,26)= 7.11, p= .01, Cohen’s d= 1.09), and for negatively valenced words (Means: BDD 1.66; 
 14 
control .19; F(1,26)= 10.91, p= .003, Cohen’s d= 1.34); but not neutral words (Means: BDD .00; 
control .06; F(1,26)= .26, p= .61, Cohen’s d= .20).  
 
 
 
 
Discussion 
This study contributes to the body of research documenting impaired neurocognitive performance in 
BDD. Differences were seen between individuals with and without BDD and cognitive results 
generally appeared to be unaffected by severity of mood and anxiety symptoms.  
Cognitive Inflexibility: The BDD group made significantly more errors on the IED task, with a 
significantly higher error rate at stage 8 of the task (the extra-dimensional shift stage- EDS). Only 
50% of the BDD group progressed to stage 8 (EDS). Results from the IED task indicates significant 
attentional (or cognitive) inflexibility within the BDD group. A number of studies have found 
deficits in cognitive flexibility in OCD patients (Veale et al., 1996; Watkins et al., 2005; 
Chamberlain et al., 2006, 2007a), with the deficits appearing exclusively at the extra-dimensional 
stage (EDS), as was the case in the current study. The neurobiology of attentional shift flexibility has 
been the subject of translational study. Research into rodents (Dias et al 1996), primates (Brown & 
Bowman 2002 ; McAlonan & Brown 2003, Hornak et al., 2004) and humans (Rogers et al., 2000; 
Nagahama et al., 2001; Hampshire & Owen, 2006) implicate the ventro-lateral prefrontal cortex (or 
functionally homologous regions) as being required for intact cognitive flexibility.  
The finding of cognitive inflexibility in the BDD group converges with published findings for OCD 
(Chamberlain, 2006) and with the clinical presentation of the disorder – specifically with the 
performance of compulsive (repetitive, urge-driven) behaviour. Individuals with BDD engage 
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compulsively in thoughts or behaviours related to appearance and find difficulty diverting attention 
to non-image related thoughts or ‘purposeful’ forms of activity. However, we cannot exclude the 
possibility that the cognitive inflexibility found in the BDD group in this study is attributable to the 
presence of comorbid OCD, which was present in 9 of the participants.  Indeed, significant 
differences were seen for completed stage errors (F(1,12)= 6.93, p=.03, Cohen’s d= 1.84), when 
comparing the participants in the BDD group who had a diagnosis of OCD with those who did not, 
suggesting that the presence of OCD may have had an influence upon cognitive flexibility. This may 
be clinically relevant, in that people with BDD comorbid with OCD may have a more rigid response 
style, which could impede ability to adjust behaviors in day-to-day life, and to engage with 
psychological treatments.  
Decision Making: The Cambridge Gambling Task (CGT) is a measure of decision-making abilities 
with the advantage of assessing different aspects of decision-making separately (Rogers et al. 
1999a,b; Deakin et al. 004). Individuals with OCD are usually unimpaired on the CGT (Chamberlain 
et al., 2007a), though abnormal performance on the task versus controls can be elicited in OCD with 
acute serotonergic challenge (Lochner et al., submitted). However, our results showed abnormal 
decision-making in a BDD sample. A higher incidence of delay aversion was seen in BDD patients 
(i.e. participants were unwilling to wait for bets to increase/decrease) suggesting an increased degree 
of impatience (decision-making impulsivity). Hollander and Wong (1995), in their investigation of 
gambling disorder and its associations with BDD, found that individuals with BDD showed an 
increased tendency for gambling. Studies have used the CGT to investigate decision-making in 
disordered gambling and substance addiction; in one recent study, participants with disordered 
gambling showed almost global impairments on the CGT including increased delay aversion as well 
as poorer quality of decision making, higher risk taking and a higher overall bet proportion,  
resembling the profile of an individual with ventromedial prefrontal cortex (vmPFC) damage. 
Individuals with disordered gambling and additional alcohol and smoking habits showed even higher 
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levels of decision making impairment (Zois, 2014).  
However, in contrast to the findings in disordered gambling, in the current study the BDD group 
demonstrated a significantly lower instance of risk taking (p=.04) and gambled a significantly 
smaller proportion of the total money gained (p <.001) than controls. Thus, unlike those with 
disordered gambling, the BDD group, despite their impatience to make bets, were if anything more 
conservative than controls in terms of other aspects of decision-making.   
Motor Impulsivity: Significant differences in motor impulsivity were found between BDD patients 
and controls on the Stop Signal Reaction Time (SSRT) task. Impaired motor response inhibition has 
been proposed to represent an endophenotype of OCD, as studies have found that unaffected 
relatives are also impaired on the SSRT (Chamberlain, 2007a). Performance on the SSRT is 
dependent on an intact right inferior frontal gyrus (Aron et al., 2003; 2004). A number of further 
brain areas have been implicated in impaired response inhibition in OCD (Menzies et al brain 2007) 
including the orbitofrontal cortex, anterior cingulate, parietal cortex, caudate-putamen and 
cerebellum, suggesting involvement of circuits within and outside the orbitofrontal –striatal -
thalamic loop.  
Overall Impulse Control: Our data suggest that participants with BDD exhibit signs of both decision-
making impulsivity and motor impulsivity. These findings align with the clinical phenomenology; 
many of the characteristic behavioural symptoms of BDD, e.g. being unable to resist the urge to 
undertake cosmetic, and even ’do it yourself (DIY)’ surgery to ‘correct’ perceived flaws, may be 
construed as poor impulse control. Indeed, Veale (2000) reported that of 25 patients he interviewed, 
nine (36%) had carried out their own DIY surgery in an attempt to dramatically alter their 
appearance. In addition, suicidal acts are common in patients with BDD. A large prospective study 
of suicide showed that in 185 BDD participants followed up over 4 years, for each year spent in the 
study an average of 57.8% reported suicidal urges, 2.6% attempted suicide and 0.3% (2 people) 
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completed suicide.   
While ‘impulsivity’ implies a predisposition toward performing rapid and unplanned reactions to 
stimuli and ‘compulsivity’ relates to the urge-driven performance of repetitive unwanted acts, both 
domains can be considered to represent a dysfunction in impulse control (Stein et al, 1996) and both 
may be represented in BDD. Separate cortico-striatal circuits are thought to sub serve impulsivity 
(ventral) and compulsivity (dorsal) (Fineberg et al., 2010). Hyperactivity of the striatal circuit 
(generation of activity) and hypoactivity of the prefrontal circuit (inhibition) may represent a 
common mechanism underpinning impulse control deficits in a range of obsessive-compulsive 
disorders such as OCD and BDD (Fineberg et al, 2010).  
Affective Processing: On the AGN task, the BDD group showed a longer reaction time between the 
presentation of a target word and a correct response i.e. they took longer to respond to the target 
word, when a correct answer was given. In addition, individuals with BDD showed a higher instance 
of errors characterised by responding to distracter stimuli (non-target words) and also a higher 
instance of non-response on target stimuli compared with controls. These data mirror previous 
findings for OCD, in which disorder inappropriate motor responses to non-target stimuli were 
observed in comparison to those seen in healthy controls (Bannon et al, 2002; Aycicegi, 2003). 
Findings in OCD studies have been specific for word valance, with negative words being more 
difficult to forget in OCD groups a potential suggestion of incorrect processing of negative words 
(Wilhelm et al, 2006) but additional findings suggest that the type of word most difficult to forget in 
OCD groups is the type associated with their current OCD presentation (positive or negative- Tolin 
et al, 2002). In the current study, individuals with BDD showed a longer reaction time, more errors 
and non-responses for positive and negative target words, but not neutral target words. Previous 
OCD research revealed elevated commission errors for neutral words, compared with happy and sad 
words, in patients in one study (Johanssen & Dittrich, 2013); while another study found more 
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omission errors for sad target words in OCD (Chamberlain et al., 2007). One interpretation for the 
current results in BDD patients is that the disorder is associated with more generalized dysregulation 
of emotional processing circuitry, with a global untoward impact of emotional information on 
attentional processing. Thus, the presentation of emotionally valenced stimuli (whether positive or 
negative) results in performance decrements that generalize across both commission and omission 
errors, with neutral stimuli not having such a pronounced effect.  
 
Also, increased errors in the BDD group to positive and negative target and distractor words could 
result from individuals with BDD being unusually sensitive to emotional cues, i.e. stimuli that have 
some meaning to the BDD disorder. These could be negative words such as ‘ugly’ or even positive 
words such as ‘attractive’. Our findings revealed differences based on word valence, and not on 
neutral word trials, suggesting that the symptoms of BDD may rely on an inherent focus on both 
negatives and positives about appearance. Additionally, this bias within the BDD condition may 
result from cognitive inflexibility, in that individuals with BDD may become ‘stuck’ in a routine of 
thinking about positive and negative aspects of themselves.  
 
The development of self - image and the role of appearance is thought to be influenced by 
environmental factors, including significant life events and shaped by memory (Bentall, 2003; 
McAdams, 1993; Osman et al., 2004). Individuals with BDD commonly report instances of bullying 
and teasing, potentially increasing their propensity for negative perception of themselves and of 
specific body parts (Osman et al., 2004, Silver et al., 2010). The finding of attentional bias toward 
affectively valenced words is consistent with this literature and may help explain how such 
experiences become overvalued and may result in an obsessive preoccupation with body image. Few 
studies have tested attention in BDD. Our findings suggest future research investigating the effect of 
 19 
BDD on attention to environmental cues, and the consequent impact on psychosocial function, is 
desirable. 
 
Limitations: Our modest BDD sample may have had reduced statistical power to detect other 
potential differences of relevance. Other BDD studies of this type have also reported a small sample 
size and it may be that recruitment to BDD studies is particularly challenging (anecdotally, our 
perception was that BDD patients seemed reluctant to engage in research that focused attention on 
themselves). Nonetheless, replication in larger samples is required.  
OCD and affective comorbidity could have had a confounding influence on the findings, considering 
75% of our BDD group had comorbid OCD and 50% comorbid depressive symptomatology. On the 
other hand, the BDD cases were drawn from a well-defined clinical cohort, BDD was recognised by 
the patients and their clinicians as the primary disorder and constituted the focus for clinical 
treatment. BDD in clinical cohorts is almost always comorbid with disorders such as OCD and 
depression (Vinkers et al., 2007; Rashid et al., 2014) and by including patients with relevant 
comorbidity, the results may be generalised to BDD patients seen in the clinical setting.  
Recognition of the influence that medication may have had on potentially changing the 
neurocognitive performance of BDD participants should be noted as all 12 of the BDD participants 
were taking medication (2 citalopram, 6 escitalopram, 3 fluvoxamine and 1 sertraline) at the time of 
testing. Certainly serotonin is known to play an important role in decision-making and emotional 
processing. Future research could be extended to investigate unaffected relatives, so as to avoid 
potential medication-related confounds. Research should also explore the functional impact of 
specific aspects of cognitive impairment on daily life, treatment-adherence, and suicidal activity.  
 
Conclusion 
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Patients with BDD were impaired compared to healthy controls on tests of cognitive flexibility, 
reward and motor impulsivity and affective processing. Results from previous studies in the OCD 
population show similar deficits in cognitive flexibility and motor impulsivity; therefore our findings 
are consistent with the re-classification of BDD with OCD.  However, the current study suggests that 
BDD may be characterized by additional abnormalities in domains of decision-making and 
emotional processing that differ from previous findings in OCD. Future work should explore the 
impact of these abnormalities on everyday functioning, ability to engage successfully with treatment 
and suicidality.  
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Tables & Figures 
 
Table 1.  Demographic analysis; BDD and control groups 
Variable 
BDD (n=12) Control (n=16)   
Mean SD Mean SD     F   
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Table 2. Clinical measures  
 
 
 
 
 
 
Note: HAM-A: Hamilton Anxiety Scale, MADRS: Montgomery-Åsberg Depression Rating Scale, 
BDD-YBOCS: Yale Brown Obsessive Compulsive Scale for Body Dysmorphic Disorder 
 
 
 
 
 
 
 
Age (years) 30.08 (8.92) 35.80 (12.10) 1.87 .18  
Education (years) 14.08 (1.88) 14.41 (1.99) 0.23 .64  
NART (IQ) 113.80 (2.95) 115.00 (3.34) 0.22 .64  
 BDD (n=12) Control (n=16)  
Mean SD Mean SD F P 
HAM-A 8.08 (6.75) 3.94 (3.04) 4.76 .03* 
MADRS 7.50 (5.98) 2.50 (4.29) 6.66 .01* 
BDD-YBOCS 13.25 (4.88) 2.38 (3.40) 48.40 <.001* 
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Table 3. MANOVA results for CANTAB tasks  
  BDD Control  
  Mean SD Mean SD F p Cohen’s d 
IED   Stages completed 8.00 1.04 8.94 .25 8.87 .007* 1.21 
  Total Errors 26.75 10.95 13.18 4.98 13.00 .001* 1.47 
EDS Errors 17.25 12.10 4.75 3.92 10.56 .003* 1.32 
CGT  Delay Aversion .47 .17 .28 .19 5.22 .03* .94 
  Deliberation Time (msec) 1827.05 741.28 2133.09 533.32 1.84 .20* .55 
Overall proportion of bet .50 .05 .76 .09 63.16 <.001* 3.24 
Risk taking .56 .06 .69 .14 1.68 .04* 1.25 
Quality of DM .89 .15 .87 .24 .45 .51 .27 
SST   Mean Reaction Time  477.19 130.99 465.57 76.36 .02 .90 .00 
  Stop Signal Reaction Time 182.64 74.84 137.81 52.62 4.66 .04* .87 
AGN Mean Correct Latency 535.00 82.31 473.22 60.78 4.85 .03* .90 
               POSITIVE 545.46 90.80 418.74 49.73 19.76 <.001* 1.81 
  
 
Total Omissions 6.92 3.40 1.19 1.64 24.44 <.001* 2.00 
              POSITIVE 1.33 1.37 .13 .34 7.11 .01*   1.09 
              NEGATIVE 1.66 1.49 .19 .40 10.90 .003* 1.34 
               NEUTRAL .00 .00 .06 .25 .26 .61 .20 
Total Commissions 10.17 7.66 4.62 2.09 5.86 .02* .96 
                POSITIVE 3.75 3.13 .75 .85 10.78 .003* 1.34 
              NEGATIVE 2.16 1.69 1.12 .72 3.74 .06 .79 
                 NEUTRAL .19 .54 .10 .42 .50 .49 .29 
Note:  * denotes a statistically significant result. IED (Intra/Extra Dimensional shift task), CGT (Cambridge 
Gambling Task), SST (Stop Signal Task), AGN (Affective Go/NoGo task) 
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Figure 1. Percentage of BDD and control participants passing each stage on the IDED task 
Note: SD = simple discrimination; SR = simple reversal; CDA = compound discrimination adjacent; CDS = compound 
discrimination superimposed; CR = compound reversal; ids = intra-dimensional shift; IDSR = intra-dimensional shift 
reversal; EDS = extra-dimensional shift; EDSR = extra-dimensional shift reversal 
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